Atlas Trials

Stem Cell Infusion in the Treatment of Patients with Neurological Sequelae After Ischemic Stroke

Clinical trial NCT05292625 · COMPLETED

Trial details

NCT number
NCT05292625
Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2020-07-07
Primary completion
2022-12-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.